- 2026.02.03
Medicine supply notification: Oxybutynin (Kentera®) 3.9mg/24hours transdermal patches
These are out of stock until late-Feb 2026. The 5mg and 10mg modified-release tablets and 2.5mg/5ml & 5mg/5ml oral solution sugar free remain available and can support increased demand. The 2.5mg & 5mg standard release tablets remain available but cannot support increased demand.
Source: Community Pharmacy England
これらは2026年2月下旬まで在庫切れです。5mgおよび10mgの緩放性錠剤、2.5mg/5mlおよび5mg/5ml経口溶液の砂糖不使用剤は引き続き利用可能で、需要増加を支えることができます。2.5mgおよび5mgの標準放出錠剤は引き続き入手可能ですが、需要増加には対応できません。
- 2026.01.27
Serious shortage protocols for Creon® 10,000 and 25,000 gastro-resistant capsules further extended
These serious shortage protocols, due to expire 16 January 2026, have now been further extended to Friday 30 January (SSP60; 10,000 capsules) and Friday 17 April 2026 (SSP61; 25,000 capsules).
Source: Community Pharmacy England
Gastrointestinal disorders Nutritional and metabolic disorders
Steps taken to resolve aspirin supply disruption
All presentations of aspirin have been added to the DHSC’s list of medicines that cannot be exported or hoarded after reports of supply issues, in order to preserve supplies. Normal supply is expected to resume over the coming weeks.
Source: Monthly Index of Medical Specialities
Cardiovascular system disorders
- 2026.01.20
Discontinuation of Subutex and Suboxone tablets
The manufacturer is no longer supplying all strengths of Subutex (buprenorphine) and Suboxone (buprenorphine and naloxone) sublingual tablets in the UK. Alternative branded and generic buprenorphine sublingual tablets remain available.
Source: Community Pharmacy England
Medicine supply notification: Buprenorphine/naloxone (Suboxone® ) 2mg/500microgram and 8mg/2mg sublingual tablets
These tablets were discontinued on 5 Jan 2026. Various strengths of short-dated buprenorphine/naloxone (Zubsolv®) sublingual tablets are available but future UK supply is to be confirmed. Branded and generic buprenorphine sublingual tablets and oral lyophilisate remain available.
Source: Community Pharmacy England
Medicine supply notification: Co-codamol 30mg/500mg tablets
There will be limited supply from early February to early June 2026. Paracetamol 500mg tablets and codeine 30mg tablets remain available and can support a full uplift in demand. Other strengths and forms of co-codamol remain available but cannot support an uplift in demand.
Source: Community Pharmacy England
Steriflex No. 109 (1L) and No. 171 (2L): potassium chloride 0.15%, sodium chloride 0.45%, glucose 2.5% bags
Fresenius Kabi are transitioning their Steriflex® range of licensed and unlicensed IV fluid bags to DEHP-free IV fluid bags and have experienced a shortage during this change due to increased demands and lack of availability of raw materials. This alert outlines management plan.
Source: Department of Health and Social Care
- 2026.01.13
Medicine supply notification: Clonidine (Catapres®) 100microgram tablets
These are out of stock until mid-Feb 2026. Clonidine 25microgram tablets and 50micrograms/5ml and 100micrograms/5ml sugar-free oral solution remain available and can support increased demand. If these are unsuitable, unlicensed supplies of 100microgram tablets may be sourced.
Source: Community Pharmacy England
Cardiovascular system disorders Neurological disordersThe 5mg and 10mg ampoules are out of stock, the 100mg ampoules are expected to become unavailable from early Jan, and the 30mg ampoules are unable to support increased demand. Morphine sulfate injection has been identified by clinical experts as the first-line alternative opioid.
Further Information
Source: Community Pharmacy England
Anaesthesia and painHypurin® Porcine 30/70 mix 100units/ml suspension for injection 3ml cartridges will be out of stock until mid-January 2026. The remaining stock expired on 31 Dec 2025. The 10ml vials are being discontinued, but stock is available until Feb 2026 and can support increased demand.
Source: Community Pharmacy England
DiabetesThis product is out of stock until early Feb 2026. Latanoprost 50micrograms/ml / Timolol 5mg/ml (Vizilatan Duo®) preservative-free (PF) eye drops remain available and can support increased demand. Separate latanoprost and timolol PF topical eye presentations are also available.
Further Information
Source: Community Pharmacy England
Eyes and visionMedicine supply notification: Nifedipine (Adipine® XL) 30mg and 60mg modified-release tablets
Nifedipine (Adipine® XL) 30mg and 60mg modified-release tablets are out of stock until the end of January 2026. Alternative brands of nifedipine 30mg and 60mg modified-release tablets remain available, but only some can support increased demand.
Further Information
Source: Community Pharmacy England
Cardiovascular system disordersThe reusable Pen device for these products will be out of stock from end Jan 2026 until at least early 2027. People whose battery life expires during this period will need switching to alternative device. Cartridges, GoQuick® pens and pre-filled disposable devices are available.
Source: Community Pharmacy England
Endocrine system disorders - 2025.12.25
Updated medicine supply notification: Fiasp® FlexTouch® (insulin aspart) 100units/ml solution for injection 3ml pre-filled pens
The notification has been updated to now advise Fiasp® FlexTouch® (insulin aspart) 100units/ml pre-filled pens have been discontinued; supplies were exhausted in March 2024.
Fiasp® FlexTouch®(インスリンアスパルト)100ユニット/mlのプリフィルペンが生産終了となりました。2024年3月には物資が尽きていましたSource: Community Pharmacy England
Diabetes
Updated medicine supply notification: Tresiba® (insulin degludec) FlexTouch® 100units/ml solution for injection 3ml prefilled pens
The notification has been updated to now advise that Tresiba® FlexTouch® 100units/ml pens have been discontinued; supplies were exhausted in July 2023.
Tresiba® FlexTouch® 100ユニット/mlペンが生産終了となったことを知らせています。2023年7月には物資が尽きていました。Source: Community Pharmacy England
Diabetes
- 2025.12.16
Medicine supply notification: Nifedipine (Fortipine® LA) 40mg modified-release tablets
2025年12月8日、保健・社会福祉省（Department of Health and Social Care：DHSC）は、Nifedipine (Fortipine® LA) 40mg徐放性錠の医薬品供給通知（medicine supply notification）を発出した。
- Nifedipine (Fortipine® LA)40mg徐放性錠剤は現在在庫切れ。再入荷日は未定。
- 他のブランドのNifedipin20mg徐放性錠剤は引き続き入手可能であり、需要増加に対応可能。
- Nifedipine (Coracten® SR) 20mg徐放性カプセルは引き続き入手可能であり、需要増加に対応可能。
- 2025.11.25
Medicine supply notification: Ibandronic acid 150mg tablets
イバンドロン酸150mg錠剤(唯一の認可済み月用ビスホスホネート)は2026年3月まで限定的に供給されています。アレンドロン酸70mg錠剤およびリセドロン酸ナトリウム35mg錠剤(週1回のビスホスホネート投与)は引き続き入手可能で、需要の増加を支えることができます
- 2025.11.18
Medicine supply notification: Propranolol 80mg and 160mg modified release capsules
プロプラノロール80mgのM/Rカプセルは2026年3月初旬まで在庫切れ、160mgのM/Rカプセルは2026年11月下旬から1月中旬から下旬まで在庫切れです。I/Rの40mgおよび80mgのタブがあり、需要の増加にも対応できます。経口用溶液は利用可能ですが、需要の増加には対応できません
- 2025.10.28
Medicine supply notification: Amiodarone 100mg and 200mg tablets
Amiodarone 100mg and 200mg tablets are in limited supply until the week commencing 17 November 2025. Amiodarone suspension remains available (specials), and unlicensed imports of amiodarone of 100mg and 200mg tablets have been sourced (lead times vary).
Source: Community Pharmacy England
Medicine supply notification: Antimicrobial agents used in tuberculosis (TB) treatment
Following the national patient safety alert issued on 29 July 2025, the supply situation for antimicrobial medicines used to treat tuberculosis has significantly improved, and updated information in this medicines supply notification supersedes the alert.
Source: Community Pharmacy England
Mometasone (Asmanex Twisthaler®) dry powder inhalers are being discontinued (200 microgram per dose, 60 dose from Oct 2025; 200 microgram per dose 60 dose and 400 microgram per dose 30 and 60 dose from Feb 2026). Alternative corticosteroid inhalers are can bridge supply gap.
Source: Community Pharmacy England
SSPs for cefalexin oral suspensions sugar free further extended
SSPs for cefalexin 125mg/5ml oral suspension sugar free (SSP077) and cefalexin 250mg/5ml oral suspension sugar free (SSP078) were due to expire on 24 October 2025 but they have now been further extended to Friday 28 November 2025.
Source: Community Pharmacy England
- 2025.10.21
Medicine supply notification: Dalivit® oral drops
Dalivit® oral drops are out of stock until further notice. Abidec® multivitamin drops remain available and can support increased demand, but as it contains arachis oil (peanut oil), it should not be taken by patients with peanut or soya allergy.
Medicine supply notification: Exenatide (Bydureon® BCise®) 2mg/0.85ml prolonged-release suspension for injection pre-filled pen
Exenatide (Bydureon® BCise®) 2mg/0.85ml prolonged-release suspension for injection pre-filled pens have been discontinued with supplies now exhausted. Alternative GLP-1 RAs and dual GIP/GLP-1 RA remain available and can support increased demand.